Cargando…

Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016

BACKGROUND: Algorithms for predicting infection with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) on hospital admission or in patients with bacteraemia have been proposed, aiming to optimise empiric treatment decisions. AIM: We sought to confirm external validity and transferab...

Descripción completa

Detalles Bibliográficos
Autores principales: Vock, Isabelle, Aguilar-Bultet, Lisandra, Egli, Adrian, Tamma, Pranita D, Tschudin-Sutter, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346366/
https://www.ncbi.nlm.nih.gov/pubmed/32643598
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.26.1900317
_version_ 1783556393291218944
author Vock, Isabelle
Aguilar-Bultet, Lisandra
Egli, Adrian
Tamma, Pranita D
Tschudin-Sutter, Sarah
author_facet Vock, Isabelle
Aguilar-Bultet, Lisandra
Egli, Adrian
Tamma, Pranita D
Tschudin-Sutter, Sarah
author_sort Vock, Isabelle
collection PubMed
description BACKGROUND: Algorithms for predicting infection with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) on hospital admission or in patients with bacteraemia have been proposed, aiming to optimise empiric treatment decisions. AIM: We sought to confirm external validity and transferability of two published prediction models as well as their integral components. METHODS: We performed a retrospective case–control study at University Hospital Basel, Switzerland. Consecutive patients with ESBL-producing Escherichia coli or Klebsiella pneumoniae isolated from blood samples between 1 January 2010 and 31 December 2016 were included. For each case, three non-ESBL-producing controls matching for date of detection and bacterial species were identified. The main outcome measure was the ability to accurately predict infection with ESBL-PE by measures of discrimination and calibration. RESULTS: Overall, 376 patients (94 patients, 282 controls) were analysed. Performance measures for prediction of ESBL-PE infection of both prediction models indicate adequate measures of calibration, but poor discrimination (area under receiver-operating curve: 0.627 and 0.651). History of ESBL-PE colonisation or infection was the single most predictive independent risk factor for ESBL-PE infection with high specificity (97%), low sensitivity (34%) and balanced positive and negative predictive values (80% and 82%). CONCLUSIONS: Applying published prediction models to institutions these were not derived from, may result in substantial misclassification of patients considered as being at risk, potentially leading to wrong allocation of antibiotic treatment, negatively affecting patient outcomes and overall resistance rates in the long term. Future prediction models need to address differences in local epidemiology by allowing for customisation according to different settings.
format Online
Article
Text
id pubmed-7346366
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-73463662020-07-14 Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016 Vock, Isabelle Aguilar-Bultet, Lisandra Egli, Adrian Tamma, Pranita D Tschudin-Sutter, Sarah Euro Surveill Research BACKGROUND: Algorithms for predicting infection with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) on hospital admission or in patients with bacteraemia have been proposed, aiming to optimise empiric treatment decisions. AIM: We sought to confirm external validity and transferability of two published prediction models as well as their integral components. METHODS: We performed a retrospective case–control study at University Hospital Basel, Switzerland. Consecutive patients with ESBL-producing Escherichia coli or Klebsiella pneumoniae isolated from blood samples between 1 January 2010 and 31 December 2016 were included. For each case, three non-ESBL-producing controls matching for date of detection and bacterial species were identified. The main outcome measure was the ability to accurately predict infection with ESBL-PE by measures of discrimination and calibration. RESULTS: Overall, 376 patients (94 patients, 282 controls) were analysed. Performance measures for prediction of ESBL-PE infection of both prediction models indicate adequate measures of calibration, but poor discrimination (area under receiver-operating curve: 0.627 and 0.651). History of ESBL-PE colonisation or infection was the single most predictive independent risk factor for ESBL-PE infection with high specificity (97%), low sensitivity (34%) and balanced positive and negative predictive values (80% and 82%). CONCLUSIONS: Applying published prediction models to institutions these were not derived from, may result in substantial misclassification of patients considered as being at risk, potentially leading to wrong allocation of antibiotic treatment, negatively affecting patient outcomes and overall resistance rates in the long term. Future prediction models need to address differences in local epidemiology by allowing for customisation according to different settings. European Centre for Disease Prevention and Control (ECDC) 2020-07-02 /pmc/articles/PMC7346366/ /pubmed/32643598 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.26.1900317 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Research
Vock, Isabelle
Aguilar-Bultet, Lisandra
Egli, Adrian
Tamma, Pranita D
Tschudin-Sutter, Sarah
Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
title Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
title_full Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
title_fullStr Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
title_full_unstemmed Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
title_short Independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing Enterobacterales, University Hospital Basel, Switzerland, January 2010 to December 2016
title_sort independent, external validation of clinical prediction rules for the identification of extended-spectrum β-lactamase-producing enterobacterales, university hospital basel, switzerland, january 2010 to december 2016
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346366/
https://www.ncbi.nlm.nih.gov/pubmed/32643598
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.26.1900317
work_keys_str_mv AT vockisabelle independentexternalvalidationofclinicalpredictionrulesfortheidentificationofextendedspectrumblactamaseproducingenterobacteralesuniversityhospitalbaselswitzerlandjanuary2010todecember2016
AT aguilarbultetlisandra independentexternalvalidationofclinicalpredictionrulesfortheidentificationofextendedspectrumblactamaseproducingenterobacteralesuniversityhospitalbaselswitzerlandjanuary2010todecember2016
AT egliadrian independentexternalvalidationofclinicalpredictionrulesfortheidentificationofextendedspectrumblactamaseproducingenterobacteralesuniversityhospitalbaselswitzerlandjanuary2010todecember2016
AT tammapranitad independentexternalvalidationofclinicalpredictionrulesfortheidentificationofextendedspectrumblactamaseproducingenterobacteralesuniversityhospitalbaselswitzerlandjanuary2010todecember2016
AT tschudinsuttersarah independentexternalvalidationofclinicalpredictionrulesfortheidentificationofextendedspectrumblactamaseproducingenterobacteralesuniversityhospitalbaselswitzerlandjanuary2010todecember2016